NCT07034092View on ClinicalTrials.gov

PATH-03 Paraguay Feasibility Study

NANot yet recruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

October 31, 2026

Conditions

Kidney Disease, End-Stage

Interventions

DEVICE

ePATH System will be used to create an endoAVF

An endoAVF will be created in subjects that need fistulas for hemodialysis

Trial Locations (1)

001207

Sanatorio Italiano, Asunción

Sponsors

Lead Sponsor

Pathfinder Medical

All Listed Sponsors

collaborator

MINSA SA

UNKNOWN

lead

Pathfinder Medical

INDUSTRY

NCT07034092 - PATH-03 Paraguay Feasibility Study | Biotech Hunter | Biotech Hunter